ProterixBio Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:ProterixBio Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011521
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProterixBio Inc (ProterixBio), formerly BioScale Inc is a medical device company that manufactures and markets the ViBE platform products. The company offers ViBE platform, acoustic assays; ViBE software and custom assays. Its ViBE platform enables non-optical detection and sensitive quantitation down to complex matrices. ProterixBio develops acoustic membrane microparticle technology, a homogeneous assay platform that improves the sensitivity and specificity of traditional reagents. The company’s research areas include pharmaceutical drug discovery and development, protein research, preclinical and clinical assays, translational biology and medicine, biochemical pharmacology, and pharmaco-kinetics and pharmaco-dynamics. Its instrumentation platform is used in biopharmaceutical companies, academic institutions and government laboratories, among others. BioScale is headquartered in Billerica, Massachusetts, the US.

ProterixBio Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ProterixBio Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ProterixBio Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ProterixBio Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ProterixBio Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
ProterixBio Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ProterixBio Inc, Medical Equipment, Deal Details 10
Venture Financing 10
BioScale Raises US$19 Million In Venture Financing 10
Bioscale Raises US$1 Million In Venture Financing 11
BioScale Raises US$3.8 Million Venture Financing Round 12
Bioscale Raises US$5.3 Million In Venture Financing 13
ProterixBio Inc – Key Competitors 14
ProterixBio Inc – Key Employees 15
ProterixBio Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Jul 13, 2016: ProterixBio Announces the Appointment of Dr. Fernando Martinez to its Scientific Advisory Board 17
Legal and Regulatory 18
May 03, 2016: BioScale Announces Company Name Change to ProterixBio and New Focus on Pulmonary Diagnostics and Disease Management 18
Product News 19
Sep 12, 2017: ProterixBio presents COPD clinical study results at the European Respiratory Society International Congress 19
Other Significant Developments 20
Jul 28, 2016: ProterixBio and the University of Zurich Receive Michael J. Fox Foundation Grant to Develop a Novel Assay for Alpha-synuclein Aggregates 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
ProterixBio Inc, Medical Equipment, Key Facts 2
ProterixBio Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ProterixBio Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ProterixBio Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ProterixBio Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ProterixBio Inc, Deals By Market, 2011 to YTD 2017 8
ProterixBio Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
BioScale Raises US$19 Million In Venture Financing 10
Bioscale Raises US$1 Million In Venture Financing 11
BioScale Raises US$3.8 Million Venture Financing Round 12
Bioscale Raises US$5.3 Million In Venture Financing 13
ProterixBio Inc, Key Competitors 14
ProterixBio Inc, Key Employees 15

★海外企業調査レポート[ProterixBio Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Famsa, S.A.B. de C.V.:戦略・SWOT・企業財務分析
    Grupo Famsa, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Famsa, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Saladax Biomedical Inc:企業の製品パイプライン分析2018
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …
  • Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • Scientex Bhd (SCIENTX):企業の財務・戦略的SWOT分析
    Summary Scientex Bhd (Scientex) is a manufacturer and supplier of packaging products and component parts for automotive interior. The company operates through stretch and custom film, converting, specialty products and property development divisions. It offers lamination base, general, barrier and a …
  • PTT Public Company Limited:企業の戦略・SWOT・財務情報
    PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nano Intelligent Biomedical Engineering Corp (138610):医療機器:M&Aディール及び事業提携情報
    Summary Nano Intelligent Biomedical Engineering Corp (NIBEC) is a venture firm. The firm manufacture of tissue regeneration devices. It aims to research ideas for tissue regeneration treatments and to develop and manufacture devices for practical use. NIBEC offers bio fusion peptide-based products, …
  • Motif BioSciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motif BioSciences Inc (Motif), a subsidiary of Motif Bio Plc is a clinical stage biopharmaceutical company that manufactures novel antibiotics designed to treat life-threatening infections caused by multi-drug resistant bacteria. The company’s product programs include MTF-001, iclaprim, and …
  • Agro Tech Foods Limited:企業の戦略・SWOT・財務情報
    Agro Tech Foods Limited - Strategy, SWOT and Corporate Finance Report Summary Agro Tech Foods Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Marksans Pharma Ltd (MARKSANS):製薬・医療:M&Aディール及び事業提携情報
    Summary Marksans Pharma Ltd (Marksans Pharma) is a pharmaceutical company that develops, manufactures and markets branded formulations and generic products. The company manufactures non-sterile liquids, ointments and powder products. It offers solid oral dosage in form of tablets, hard gelatin capsu …
  • L’Oreal USA, Inc.:企業の戦略的SWOT分析
    L'Oreal USA, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • China National Electronics Import & Export Corporation:戦略・SWOT・企業財務分析
    China National Electronics Import & Export Corporation - Strategy, SWOT and Corporate Finance Report Summary China National Electronics Import & Export Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company' …
  • SINTEF:企業の戦略的SWOT分析
    SINTEF - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Spindletop Oil & Gas Co (SPND):企業の財務・戦略的SWOT分析
    Summary Spindletop Oil & Gas Co (Spindletop Oil & Gas) is an oil and gas exploration and production company. The company explores, develops and produces crude oil and natural gas in North America. It owns and maintains natural gas pipeline in Texas. Spindletop Oil & Gas also operates various gas pip …
  • Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude …
  • HearMeOut Ltd (HMO):企業の財務・戦略的SWOT分析
    HearMeOut Ltd (HMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Bel Fuse, Inc.:企業の戦略・SWOT・財務情報
    Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • HDR Inc:企業の戦略的SWOT分析
    HDR Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Samchully Co Ltd (004690):企業の財務・戦略的SWOT分析
    Samchully Co Ltd (004690) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Calgary Scientific Inc:医療機器:M&Aディール及び事業提携情報
    Summary Calgary Scientific Inc (Calgary Scientific) is a medical imaging company that provides research and diagnostic technologies for the medical industry. The company offers ResolutionMD, is a zero-footprint enterprise viewing platform, which is installed in healthcare facilities and used to view …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆